Subsequently, CD8+ T cells may represent the main drivers of the pro-tumor effect, as seen in chronic inflammatory diseases and recently in HCC promoting inflammation in the NTME in an NKG2D-dependent, TCR-independent manner. The gene discussed is CD8A; the disease is hepatocellular carcinoma.